METHOTREXATE BELLON
METHOTREXATE
Public price
21,20 MAD
Active substance
METHOTREXATE
Laboratory
MAPHAR
Reimbursable
What is this medicine?
A dihydrofolate reductase inhibitor that interferes with DNA synthesis, repair, and cellular replication.
Verified summary
METHOTREXATE, SOLUTION INJECTABLE, 5 MG / 2 ML, BOITE DE 1 FLACON
Common uses
Acute lymphoblastic leukemia (ALL),Mycosis fungoides,Relapsed or refractory non-Hodgkin lymphoma,Rheumatoid arthritis,Polyarticular juvenile idiopathic arthritis (pJIA),Severe psoriasis
Class
Dihydrofolate reductase inhibitor
Laboratory
MAPHAR
Availability note
Reimbursable
Hospital price
13,20 MAD
Strength
5 MG / 2 ML
Form
SOLUTION INJECTABLE
Presentation
BOITE DE 1 FLACON
Commercial status
Retiré du Marché
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: 21,20 MAD
Available presentations and strengths
Medicines with the same active substance
METHOTREXATE BELLON (H)
500 MG · 10 FLACON 20 ML
0,00 MAD
METHOTREXATE MYLAN
25 MG / ML · BOITE DE 10 FLACON DE 20 ML
1,34 MAD
METHOTREXATE MYLAN
25 MG / ML · BOITE DE 1 FLACON DE 200ML
1,39 MAD
METHOTREXATE MYLAN
100 MG / ML · BOITE DE 10 FLACONS DE 10 ML
3,44 MAD
METHOTREXATE MYLAN
100 MG / ML · BOITE DE 10 FLACON DE 50ML
11,07 MAD
TREXA
2,5 MG · BOITE DE 24
28,10 MAD
METHOTREXATE BIODIM
5 MG · 1 FLACON 2 ML
30,70 MAD
METHOTREXATE BIODIM
5 MG · BOITE DE 1 FLACON
38,10 MAD
METHOTREXATE BIODIM
25 MG · 1 FLACON 1 ML
47,10 MAD
TREXA
10 MG · BOITE DE 15
49,10 MAD
TREXIMED
50 MG / 2 ML (25 MG / ML) · BOITE DE 1
62,10 MAD
TREXIMED 50 MG / 2 ML
50 MG / 2 ML · Flacon de 2 ml
62,10 MAD